Cargando…
Potential and Challenges of Aptamers as Specific Carriers of Therapeutic Oligonucleotides for Precision Medicine in Cancer
Due to the progress made in the area of precision and personalized medicine in the field of cancer therapy, strategies to selectively and specifically identify target molecules causative of the diseases are urgently needed. Efforts are being made by a number of different laboratories, companies, and...
Autores principales: | Nuzzo, Silvia, Roscigno, Giuseppina, Affinito, Alessandra, Ingenito, Francesco, Quintavalle, Cristina, Condorelli, Gerolama |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826972/ https://www.ncbi.nlm.nih.gov/pubmed/31636244 http://dx.doi.org/10.3390/cancers11101521 |
Ejemplares similares
-
The Role of Exo-miRNAs in Cancer: A Focus on Therapeutic and Diagnostic Applications
por: Ingenito, Francesco, et al.
Publicado: (2019) -
Identification of a novel RNA aptamer that selectively targets breast cancer exosomes
por: Esposito, Carla Lucia, et al.
Publicado: (2021) -
miR-216a Acts as a Negative Regulator of Breast Cancer by Modulating Stemness Properties and Tumor Microenvironment
por: Roscigno, Giuseppina, et al.
Publicado: (2020) -
miR-34c-3p targets CDK1 a synthetic lethality partner of KRAS in non-small cell lung cancer
por: Palma, Francesco, et al.
Publicado: (2020) -
The Discovery of RNA Aptamers that Selectively Bind Glioblastoma Stem Cells
por: Affinito, Alessandra, et al.
Publicado: (2019)